Another popular blood-pressure medicine recalled for carcinogen risk Posted by: Stonecom Interactive Thursday, June 27, 2019 FDA warns the risk of a few people developing cancer after long-term use of losartin can’t be ruled out Source 2019-06-27 Stonecom Interactive